Integrated experimental-computational analysis of a HepaRG liver-islet microphysiological system for human-centric diabetes research

被引:6
作者
Casas, Belen [1 ,2 ]
Vilen, Liisa [1 ]
Bauer, Sophie [3 ]
Kanebratt, Kajsa P. [1 ]
Huldt, Charlotte Wennberg [4 ]
Magnusson, Lisa [4 ]
Marx, Uwe [3 ]
Andersson, Tommy B. [1 ]
Gennemark, Peter [1 ,2 ]
Cedersund, Gunnar [2 ,5 ]
机构
[1] AstraZeneca, Drug Metab & Pharmacokinet, Res & Early Dev, Cardiovasc Renal & Metab CVRM,BioPharmaceut R&D, Gothenburg, Sweden
[2] Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden
[3] TissUse GmbH, Berlin, Germany
[4] AstraZeneca, Biosci, Res & Early Dev, Renal & Metab CVRM,BioPharmaceut R&D, Gothenburg, Sweden
[5] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden
基金
瑞典研究理事会; 欧盟地平线“2020”;
关键词
PANCREATIC BETA-CELLS; ON-A-CHIP; MULTI-ORGAN-CHIP; GLUCOSE-TOLERANCE; INSULIN SENSITIVITY; ANIMAL-MODELS; IN-VITRO; MASS; RAT; GLUCONEOGENESIS;
D O I
10.1371/journal.pcbi.1010587
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Microphysiological systems (MPS) are powerful tools for emulating human physiology and replicating disease progression in vitro. MPS could be better predictors of human outcome than current animal models, but mechanistic interpretation and in vivo extrapolation of the experimental results remain significant challenges. Here, we address these challenges using an integrated experimental-computational approach. This approach allows for in silico representation and predictions of glucose metabolism in a previously reported MPS with two organ compartments (liver and pancreas) connected in a closed loop with circulating medium. We developed a computational model describing glucose metabolism over 15 days of culture in the MPS. The model was calibrated on an experiment-specific basis using data from seven experiments, where HepaRG single-liver or liver-islet cultures were exposed to both normal and hyperglycemic conditions resembling high blood glucose levels in diabetes. The calibrated models reproduced the fast (i.e. hourly) variations in glucose and insulin observed in the MPS experiments, as well as the long-term (i.e. over weeks) decline in both glucose tolerance and insulin secretion. We also investigated the behaviour of the system under hypoglycemia by simulating this condition in silico, and the model could correctly predict the glucose and insulin responses measured in new MPS experiments. Last, we used the computational model to translate the experimental results to humans, showing good agreement with published data of the glucose response to a meal in healthy subjects. The integrated experimental-computational framework opens new avenues for future investigations toward disease mechanisms and the development of new therapies for metabolic disorders.
引用
收藏
页数:34
相关论文
共 97 条
[81]   A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies [J].
Serras, Ana S. ;
Rodrigues, Joana S. ;
Cipriano, Madalena ;
Rodrigues, Armanda V. ;
Oliveira, Nuno G. ;
Miranda, Joana P. .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[82]   An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations [J].
Silber, Hanna E. ;
Jauslin, Petra M. ;
Frey, Nicolas ;
Gieschke, Ronald ;
Simonsson, Wrika S. H. ;
Karlsson, Mats O. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09) :1159-1171
[83]   Physiome-on-a-Chip: The Challenge of "Scaling" in Design, Operation, and Translation of Microphysiological Systems [J].
Stokes, C. L. ;
Cirit, M. ;
Lauffenburger, D. A. .
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2015, 4 (10) :559-562
[84]   Type 2 diabetes: principles of pathogenesis and therapy [J].
Stumvoll, M ;
Goldstein, BJ ;
van Haeften, TW .
LANCET, 2005, 365 (9467) :1333-1346
[85]   Strategies for using mathematical modeling approaches to design and interpret multi-organ microphysiological systems (MPS) [J].
Sung, Jong Hwan ;
Wang, Ying ;
Shuler, Michael L. .
APL BIOENGINEERING, 2019, 3 (02)
[86]   A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip [J].
Sung, Jong Hwan ;
Kam, Carrie ;
Shuler, Michael L. .
LAB ON A CHIP, 2010, 10 (04) :446-455
[87]   THE ROLE OF GLUCOSE IN THE INVITRO REGULATION OF CELL-CYCLE KINETICS AND PROLIFERATION OF FETAL PANCREATIC B-CELLS [J].
SWENNE, I .
DIABETES, 1982, 31 (09) :754-760
[88]   In-Depth Proteome Analysis Highlights HepaRG Cells as a Versatile Cell System Surrogate for Primary Human Hepatocytes [J].
Tascher, Georg ;
Burban, Audrey ;
Camus, Sandrine ;
Plumel, Marine ;
Chanon, Stephanie ;
Le Guevel, Remy ;
Shevchenko, Valery ;
Van Dorsselaer, Alain ;
Lefai, Etienne ;
Guguen-Guillouzo, Christiane ;
Bertile, Fabrice .
CELLS, 2019, 8 (02)
[89]   A model of β-cell mass, insulin, and glucose kinetics:: Pathways to diabetes [J].
Topp, B ;
Promislow, K ;
de Vries, G ;
Miura, RM ;
Finegood, DT .
JOURNAL OF THEORETICAL BIOLOGY, 2000, 206 (04) :605-619
[90]   Dynamics of insulin sensitivity, β-cell function, and β-cell mass during the development of diabetes in falfa rats [J].
Topp, Brian G. ;
Atkinson, Laura L. ;
Finegood, Diane T. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (06) :E1730-E1735